1/13
04:27 pm
insm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
1/12
06:02 pm
insm
Insmed CEO Will Lewis talks its rare disease drug pipeline [CNBC]
Medium
Report
Insmed CEO Will Lewis talks its rare disease drug pipeline [CNBC]
1/12
01:05 pm
insm
Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Truist Financial Corporation.
1/10
10:52 pm
insm
Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? [Yahoo! Finance]
Medium
Report
Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? [Yahoo! Finance]
1/10
07:02 pm
insm
The Bull Case For Insmed (INSM) Could Change Following Bold 2025 Revenue Guidance Hike - Learn Why [Yahoo! Finance]
Medium
Report
The Bull Case For Insmed (INSM) Could Change Following Bold 2025 Revenue Guidance Hike - Learn Why [Yahoo! Finance]
1/9
07:37 am
insm
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/9
07:00 am
insm
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
1/8
10:05 am
insm
Insmed (NASDAQ:INSM) was given a new $157.00 price target on by analysts at Morgan Stanley.
Low
Report
Insmed (NASDAQ:INSM) was given a new $157.00 price target on by analysts at Morgan Stanley.
1/8
10:00 am
insm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
1/8
07:31 am
insm
Jim Cramer on Insmed: “This One Is Worth Keeping an Eye On” [Yahoo! Finance]
Low
Report
Jim Cramer on Insmed: “This One Is Worth Keeping an Eye On” [Yahoo! Finance]
1/6
06:31 pm
insm
What Catalysts Are Quietly Shifting The Narrative For Insmed (INSM)? [Yahoo! Finance]
Low
Report
What Catalysts Are Quietly Shifting The Narrative For Insmed (INSM)? [Yahoo! Finance]
1/6
11:48 am
insm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
1/6
09:02 am
insm
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/2
07:00 am
insm
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
1/1
10:00 am
insm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
12/30
12:37 pm
insm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
12/29
09:29 pm
insm
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
Low
Report
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
12/22
07:54 am
insm
Columbia Select Large Cap Growth Fund Q3 2025 Commentary [Seeking Alpha]
Low
Report
Columbia Select Large Cap Growth Fund Q3 2025 Commentary [Seeking Alpha]
12/20
07:27 am
insm
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Low
Report
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
12/19
06:08 am
insm
Insmed (NASDAQ:INSM) was given a new $202.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Insmed (NASDAQ:INSM) was given a new $202.00 price target on by analysts at Truist Financial Corporation.
12/18
07:02 pm
insm
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]
Medium
Report
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]
12/18
05:52 pm
insm
Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]
Medium
Report
Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]
12/18
12:59 pm
insm
Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.
Low
Report
Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.
12/18
11:58 am
insm
Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says [Yahoo! Finance]
Low
Report
Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says [Yahoo! Finance]
12/18
11:24 am
insm
Insmed's ‘win streak' ends as top drug fails study in chronic nasal condition [Yahoo! Finance]
Low
Report
Insmed's ‘win streak' ends as top drug fails study in chronic nasal condition [Yahoo! Finance]